AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Brian
J.G. Pereira, MD, President and Chief Executive Officer, will present an
overview of the Company at the Eighth Annual Needham Life Sciences
Conference on June 11, 2009 at 10:00 a.m. ET. The conference is being
held in New York City.
A live audio webcast of the presentation will be accessible through the
Investors section of the Company’s website at www.amagpharma.com.
Following the conference, the webcast will be archived on the AMAG
Pharmaceuticals, Inc. website until June 25, 2009.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes
its proprietary technology for the development and commercialization of
a therapeutic iron compound to treat anemia and novel imaging agents to
aid in the diagnosis of cancer and cardiovascular disease.
Feraheme™ (ferumoxytol injection) is being developed for use as an
intravenous iron replacement therapeutic agent for the treatment of iron
deficiency anemia and as a diagnostic agent for vascular-enhanced
magnetic resonance imaging to assess peripheral arterial disease.
AMAG Pharmaceuticals, Inc.
Carol Miceli, 617-498-3361
